159 related articles for article (PubMed ID: 2434277)
21. Radionuclide-targeted therapy for the management of metastatic bone pain.
Ackery D; Yardley J
Semin Oncol; 1993 Jun; 20(3 Suppl 2):27-31. PubMed ID: 7684862
[TBL] [Abstract][Full Text] [Related]
22. [The efficacy of therapy using 89Sr-strontium chloride in 200 patients with bone metastases of a prostatic cancer].
Haesner M; Buchali K; Pink V; Lips H
Nuklearmedizin; 1992 Mar; 31(2):48-52. PubMed ID: 1373485
[TBL] [Abstract][Full Text] [Related]
23. Autopsy of a cadaver containing strontium-89-chloride.
Schraml FV; Parr LF; Ghurani S; Silverman ED
J Nucl Med; 1997 Mar; 38(3):380-2. PubMed ID: 9074523
[TBL] [Abstract][Full Text] [Related]
24. Strontium-89 chloride in the treatment of bone metastases from breast cancer.
Baziotis N; Yakoumakis E; Zissimopoulos A; Geronicola-Trapali X; Malamitsi J; Proukakis C
Oncology; 1998; 55(5):377-81. PubMed ID: 9732212
[TBL] [Abstract][Full Text] [Related]
25. [Palliative pain relief treatment for multiple bone metastases by strontium-89].
Nishio M
Nihon Rinsho; 2011 Jun; 69 Suppl 5():581-5. PubMed ID: 22208048
[No Abstract] [Full Text] [Related]
26. A prospective, randomised double-blind crossover study to examine the efficacy of strontium-89 in pain palliation in patients with advanced prostate cancer metastatic to bone.
Lewington VJ; McEwan AJ; Ackery DM; Bayly RJ; Keeling DH; Macleod PM; Porter AT; Zivanovic MA
Eur J Cancer; 1991; 27(8):954-8. PubMed ID: 1716935
[TBL] [Abstract][Full Text] [Related]
27. Radionuclide therapy for painful bone metastases. An Italian multicentre observational study. Writing Committee of an Ad Hoc Study Group.
Piffanelli A; Dafermou A; Giganti M; Colamussi P; Pizzocaro C; Bestagno M;
Q J Nucl Med; 2001 Mar; 45(1):100-7. PubMed ID: 11456368
[TBL] [Abstract][Full Text] [Related]
28. Dose estimation in strontium-89 radiotherapy of metastatic prostatic carcinoma.
Breen SL; Powe JE; Porter AT
J Nucl Med; 1992 Jul; 33(7):1316-23. PubMed ID: 1613572
[TBL] [Abstract][Full Text] [Related]
29. [Comparison of rhenium-188, rhenium-186-HEDP and strontium-89 in palliation of painful bone metastases].
Liepe K; Franke WG; Kropp J; Koch R; Runge R; Hliscs R
Nuklearmedizin; 2000 Sep; 39(6):146-51. PubMed ID: 11057405
[TBL] [Abstract][Full Text] [Related]
30. [Effectiveness of repeated systematic radiotherapy for generalized prostate cancer].
Kiselev EN; Korytova LI; Karelin MI
Vopr Onkol; 2005; 51(6):689-91. PubMed ID: 17037036
[TBL] [Abstract][Full Text] [Related]
31. 89Sr therapy: strontium plasma clearance in disseminated prostatic carcinoma.
Blake GM; Wood JF; Wood PJ; Zivanovic MA; Lewington VJ
Eur J Nucl Med; 1989; 15(1):49-54. PubMed ID: 2537216
[TBL] [Abstract][Full Text] [Related]
32. Systemic radionuclide therapy with strontium chloride Sr 89 for painful skeletal metastases in prostate and breast cancer.
Patel BR; Flowers WM
South Med J; 1997 May; 90(5):506-8. PubMed ID: 9160068
[TBL] [Abstract][Full Text] [Related]
33. Bone marrow suppression after strontium-89 therapy and local radiation therapy in patients with diffuse marrow involvement.
Powsner RA; Zietman AL; Foss FM
Clin Nucl Med; 1997 Mar; 22(3):147-50. PubMed ID: 9067666
[TBL] [Abstract][Full Text] [Related]
34. Treatment with radioactive (89)strontium for patients with bone metastases from prostate cancer.
Jager PL; Kooistra A; Piers DA
BJU Int; 2000 Nov; 86(8):929-34. PubMed ID: 11069429
[No Abstract] [Full Text] [Related]
35. Bone pain palliation with 85Sr therapy.
Giammarile F; Mognetti T; Blondet C; Desuzinges C; Chauvot P
J Nucl Med; 1999 Apr; 40(4):585-90. PubMed ID: 10210217
[TBL] [Abstract][Full Text] [Related]
36. [Radionuclide therapy for painful bone metastases].
Szefer J; Zuchora Z
Wiad Lek; 2004; 57(5-6):280-3. PubMed ID: 15518077
[TBL] [Abstract][Full Text] [Related]
37. Radioactive strontium-89 for painful bone metastases.
Med Lett Drugs Ther; 1993 Oct; 35(908):102. PubMed ID: 7692227
[No Abstract] [Full Text] [Related]
38. [Therapeutic efficacy of strontium-89-chloride for bone metastatic tumors without bone pain].
Ouyang W; Liu JH; Liu WY
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):390-1. PubMed ID: 17426002
[TBL] [Abstract][Full Text] [Related]
39. Strontium-89 radionuclide therapy: a dosimetric study using impulse response function analysis.
Blake GM; Gray JM; Zivanovic MA; McEwan AJ; Fleming JS; Ackery DM
Br J Radiol; 1987 Jul; 60(715):685-92. PubMed ID: 3620827
[TBL] [Abstract][Full Text] [Related]
40. Strontium-89 as an adjuvant to external beam radiation improves pain relief and delays disease progression in advanced prostate cancer: results of a randomized controlled trial.
Porter AT; McEwan AJ
Semin Oncol; 1993 Jun; 20(3 Suppl 2):38-43. PubMed ID: 7684865
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
